|
RTOG names TRP subcommittee liaisons
 June 18, 2012 -- The Radiation Therapy Oncology Group (RTOG) has named James Hodge, PhD, as the liaison for the Translational Research Program (TRP) Committee's new immunomodulation subcommittee and Peter Houghton, PhD, as liaison for TRP's sarcoma subcommittee.
To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
| |
|
|
New AuntMinnie.com Members
|
Becoming a Member is FREE!
|
Real-time radiology-specific news
Case of the Day and Teaching Files
Focused topics digital communities
Lively, discussion groups
Medical imaging bookstore
SalaryScan
Job Boards
OnLine CMe/CE
Bookstore, market reports, more …
Conference Calendar
User-controlled eNewsletters
… registration is FREE and easy!
|
| |
|
The TRP informs basic science committees and working groups about important emerging research in tumor biology, chemical and biological modifiers, and pathology, according to RTOG. Its objective is to facilitate the communication of scientific ideas into RTOG clinical trials.
Hodge is director of the Recombinant Vaccine Group in the National Cancer Institute's Laboratory of Tumor Immunology and Biology. His work has focused on the design and development of novel recombinant vaccines and vaccine strategies for cancer immunotherapy, according to RTOG.
Houghton, director of the Center for Childhood Cancer and Blood Diseases at Nationwide Children's Hospital, specializes in research on childhood solid tumors, RTOG said. He also directs the national Pediatric Preclinical Testing Program. | |
|